Article Details

ResApp Health (ASX:RAP) submits obstructive sleep apnoea platform to FDA - The Market Herald

Retrieved on: 2021-10-10 23:59:39

Tags for this article:

Click the tags to see associated articles and topics

ResApp Health (ASX:RAP) submits obstructive sleep apnoea platform to FDA - The Market Herald. View article details on hiswai:

Excerpt

ResApp Health (RAP) submits a 510(k) pre-market notification to the US Food and Drug Administration (FDA) for its obstructive sleep apnoea platform ...

Article found on: themarketherald.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up